The First-and-Only Completed Stemless Reverse IDE in the USA DALLAS, Jan. 27, 2022 /PRNewswire/ -- FX has completed the enrollment for their Investigational Device Exemption [IDE] study [G180100] on the Easytech Reversed® Stemless...
LONDON, Jan. 26, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN,NYSE:SNN), the global medical technology business, today announces the expansion of indications on its CORI Surgical System - the industry's most advanced and efficient1,* handheld...
Case to be Presented at 2022 Advanced Shoulder Arthroplasty Meeting on Jan. 21 ST. LOUIS--(BUSINESS WIRE)--Stryker, one of the world’s leading medical technology companies, announced today that its new Tornier Perform® Patient-Matched...
Clearance is for use in the lumbar portion of the $5 billion instrumented fusion market* DEERFIELD, Ill., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical...
SANUWAVE will hold a conference call on Wednesday, January 19, 2022, at 9am ET to discuss its recent business activity SUWANEE, GA, Jan. 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health,...
The investment enables Texas-area orthopedic and spine practices to maintain autonomy while achieving the benefits of scale and serves as a cornerstone for Novum’s new orthopedic practice management platform DALLAS &...
Full-year 2021 U.S. organic revenue growth of 50% to 51% driven primarily by accelerated PTP™ adoptionFourth quarter 2021 U.S. organic revenue growth of 41% to 42%Full-year 2022 total revenue expected...
The Quantum Titanium Cervical Plate System showcases the benefits of additive manufacturing in bringing game-changing designs to market that ultimately impact patient care. SAN ANTONIO, TEXAS (PRWEB) JANUARY 10, 2022 Nvision Biomedical Technologies and Watershed...
NEW YORK, Jan. 6, 2022 /PRNewswire/ -- Viscogliosi Brothers Acquisition Corp. (the "Company") announced today that it priced its initial public offering of 7,500,000 units at $10.00 per unit. The units are expected to be...
Attrax Putty is the first and only synthetic biologic to receive 510(k) clearance for use with thoracolumbar interbody systems. SAN DIEGO, Jan. 5, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology...